November 16, 2016 06:59 AM ESTUpdated November 17, 03:49 PM
Financing
Startups

GSK vet Ja­son Gard­ner takes the helm of Ma­gen­ta, emerg­ing from stealth with a $48.5M round

John Carroll

Editor & Founder

Ja­son Gard­ner, Ma­gen­ta CEO. Jen Ran­dall Pho­tog­ra­phy.
Ja­son Gard­ner re­turned to his old stomp­ing grounds in Cam­bridge, MA back in the fall of 2014 with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

J&J part­ners on STAT6; As­traZeneca, Dai­ichi with­draw lung can­cer drug EMA app

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

A service from the Financial Times